OH2 Injection in Melanoma
Clinical trial NCT05868707 · RECRUITING
Trial details
- NCT number
- NCT05868707
- Sponsor
- Binhui Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2026-03-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.